These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8761730)

  • 1. Glycosyltransferases as targets for inhibition of cell wall synthesis in M. tuberculosis and M. avium.
    Maddry JA; Suling WJ; Reynolds RC
    Res Microbiol; 1996; 147(1-2):106-12. PubMed ID: 8761730
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
    Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
    J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime.
    Abate G; Hoffner SE
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):119-22. PubMed ID: 9294701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcalorimetric studies of the initial interaction between antimycobacterial drugs and Mycobacterium avium.
    Hoffner SE; Svenson SB; Beezer AE
    J Antimicrob Chemother; 1990 Mar; 25(3):353-9. PubMed ID: 2338413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Rao M; Sood R; Malhotra S; Fatma T; Upadhyay DJ; Rattan A
    J Chemother; 2006 Apr; 18(2):144-50. PubMed ID: 16736882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethambutol-sugar hybrids as potential inhibitors of mycobacterial cell-wall biosynthesis.
    Reynolds RC; Bansal N; Rose J; Friedrich J; Suling WJ; Maddry JA
    Carbohydr Res; 1999 Apr; 317(1-4):164-79. PubMed ID: 10466213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.
    Zhanel GG; Saunders MH; Wolfe JN; Hoban DJ; Karlowsky JA; Kabani AM
    Antimicrob Agents Chemother; 1998 Jan; 42(1):184-7. PubMed ID: 9449284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
    Yamori S; Ichiyama S; Shimokata K; Tsukamura M
    Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Van Ginkel SZ; Wright EL; Barrow WW
    Res Microbiol; 1996; 147(1-2):97-105. PubMed ID: 8761729
    [No Abstract]   [Full Text] [Related]  

  • 12. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex.
    Yamori S; Tsukamura M
    Microbiol Immunol; 1991; 35(10):921-6. PubMed ID: 1779893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpromazine: a drug potentially useful for treating mycobacterial infections.
    Crowle AJ; Douvas GS; May MH
    Chemotherapy; 1992; 38(6):410-9. PubMed ID: 1288966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.
    Rastogi N; Goh KS; Labrousse V
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):954-8. PubMed ID: 8187794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitubercular effect of ethambutol in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):637-44. PubMed ID: 4981784
    [No Abstract]   [Full Text] [Related]  

  • 16. New insights on Ethambutol Targets in Mycobacterium tuberculosis.
    Ghiraldi-Lopes LD; Campanerut-Sá PAZ; Evaristo GPC; Meneguello JE; Fiorini A; Baldin VP; de Souza EM; de Lima Scodro RB; Siqueira VLD; Cardoso RF
    Infect Disord Drug Targets; 2019; 19(1):73-80. PubMed ID: 29366429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of mycobacteria to fusidic acid.
    Hoffner SE; Olsson-Liljequist B; Rydgård KJ; Svenson SB; Källenius G
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):294-7. PubMed ID: 2112466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.